Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Jul 23;16(7):e0254995. doi: 10.1371/journal.pone.0254995

Effects of self-management programs on behavioral modification among individuals with chronic disease: A systematic review and meta-analysis of randomized trials

Sunju Kim 1, Moonkyoung Park 2, Rhayun Song 2,*
Editor: Sally Spencer3
PMCID: PMC8301623  PMID: 34297741

Abstract

The prevalence of chronic disease associated with unhealthy lifestyles has been increasing worldwide. Health professionals have recognized that self-management programs (SMPs) can provide health benefits by promoting health behaviors, especially when applied to individuals with lifestyle-related chronic disease. This review performed a meta-analysis of the features of SMPs using randomized studies and analyzed the magnitude of the combined effects of self-management on behavioral modification. We searched the PubMed, CINAHL, ScienceDirect, SCOPUS, Web of Science, Embase, Cochrane Library, DBpia, and KISS to identify randomized trials that evaluated the behavioral outcomes of SMPs. Subgroup analyses were performed for program duration, providers, type of comparisons, and program settings. We selected 25 studies (N = 5,681) to perform analyses with random-effects models. The effect sizes of SMPs were small but significant for physical activity (standardized difference in means [SDM] = 0.25), dietary habits (SDM = 0.28), and health responsibility (SDM = 0.18), and not significant for stress management and smoking behaviors. A short-term SMPs (less than 12 weeks) was indicated as being effective in modifying physical activity, dietary habits, and health responsibility, while the program effects on dietary habits were significant only with expert-delivered education and when compared with inactive controls. The findings of this study indicate that SMPs can effectively improve physical activity, dietary habits, and health responsibility in individuals with chronic disease, with a small but significant effect size. Future studies should explore the effects of SMPs on stress management and smoking cessation and assess the long-term maintenance of healthy lifestyles in individuals with lifestyle-related chronic disease.

Introduction

Chronic disease associated with unhealthy lifestyle is currently the most common cause of mortality worldwide, accounting for approximately 31% of all deaths [1, 2]. Modifiable factors that contribute to the development of lifestyle-related chronic disease include smoking, high cholesterol, poor dietary habits, lack of physical activity, stress, and obesity [3]. Interventions for preventing lifestyle-related chronic diseases focus on managing modifiable cardiovascular risk factors, long-term behavioral modifications that increase physical activity, improving dietary habits, improving health responsibility and stress management, and cessation of smoking and alcohol consumption [4].

Among the various interventions for managing lifestyle-related chronic disease, a self-management program (SMP) based on an evidence-based disease prevention model focuses on behavioral modifications and self-management strategies in adults with chronic disease [5]. The goal of an SMP is to manage the health conditions of patients with chronic disease, improve their health status, and reduce their medical costs. Since most of the lifestyle-related chronic disease is dependent on self-management, behavioral modification through SMP is considered the most important treatment strategy. Most adults with lifestyle-related chronic disease, however, do not follow their recommended treatment regimens or maintain the modifications in their lifestyle in the long term [69]. Previous randomized controlled trials (RCTs) of patients with chronic disease and modifiable cardiovascular risk factors have consistently found that SMPs have positive effects on behavioral modifications, which leads to risk reduction and improved quality of life [1012]. While a previous meta-analysis of SMPs mostly examined physiological outcomes for patients with chronic diseases [13], SMPs focus on the behavioral aspect of chronic disease management, for which those with lifestyle-related chronic disease have not been specifically assessed.

This study therefore aimed to identify randomized studies that used an SMP to improve the performance of health behaviors and to determine the size of the program’s combined effect on physical activity, dietary habits, health responsibility, stress management, and smoking in patients with lifestyle-related chronic disease and modifiable cardiovascular risk factors.

Materials and method

Search strategy

We searched for studies published from 2000 to December 2020 using international databases such as PubMed, CINAHL, ScienceDirect, SCOPUS, Web of Science, Embase, Cochrane Library, and Korean databases such as DBpia and KISS. This study conformed to the guidelines of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) [14]. The PICO (participants, interventions, comparisons and outcomes) framework was applied to our literature search. Search terms included various spellings and transliterations of self-management and lifestyle-disease keywords. The review protocol was registered at http://www.crd.york.ac.uk/PROSPERO (Registration number: CRD42021247523).

An example search strategy for PubMed was as follows: (((hypertension [MeSH Terms]) OR (diabetes [MeSH Terms]) OR (dyslipidemia [MeSH Terms]) OR (overweight [MeSH term]) OR (stroke [MeSH Terms]) OR (arthritis [MeSH Terms]) OR ((chronic* [All Fields]) AND (disease* [All Fields]))) NOT ((pulmonary disease, chronic obstructive [MeSH Terms]))) AND (((self [All Fields]) AND (management* [All Fields])) OR ((self management [All Fields]) AND support* [All Fields])) OR ((self [All Fields]) AND (regulation* [All Fields])) OR ((self [All Fields]) AND (monitoring [All Fields]))). Bibliographies of the retrieved articles national and international dissertations, conference proceedings and Google Scholar were used to perform manual searches for additional studies and grey literature.

PICO framework

Adult participants (≥18 years old) with lifestyle-related chronic diseases and modifiable cardiovascular risk factors were included, such as diabetes, hypertension, hyperlipidemia, and obesity. The study intervention was an SMP alongside the basic mechanism of self-efficacy. The comparison was a control group provided with usual care, no treatment, health education, motivational interviewing, or group based exercise or mindful eating. The outcomes were specific health behaviors in association with modifiable cardiovascular risk factors, including physical activity, dietary habits, health responsibility, stress management, and smoking-related behavior [15].

The behavior modification activities that we focused on were everyday physical movements or regular exercise. Dietary habits referred to the extent to which the diet was healthy and balanced [16, 17]. Health responsibility referred to behavioral lifestyle changes with knowledge based personal and social responsibility, such as health care utilization, glucose monitoring, and medication adherence [18, 19]. Stress management involved managing stress to reduce cardiovascular disease and mortality risk [20]. Smoking-related behaviors comprised smoking cessation [21, 22] and tobacco dependence [23].

Inclusion and exclusion criteria

The following inclusion criteria were developed: (1) RCTs on lifestyle-related chronic disease populations and published in English and Korean, (2) interventions conducted when an SMP was used regardless of its delivery mode or intensity, (3) presence of lifestyle-related chronic disease and modifiable cardiovascular risk factors such as diabetes, hypertension, hyperlipidemia, and obesity, and (4) assessments conducted on the behavioral outcomes of cardiac health behaviors (physical activity, dietary habits, health responsibility, stress management, and smoking). The exclusion criteria were (1) SMP conducted alongside other intervention programs, (2) inclusion of subjects with chronic diseases not related to modifiable cardiovascular risk factors, such as kidney disease, cancer, or arthritis, and (3) no pertinent data reported for the meta-analysis.

Study selection (assessment of the risk of bias in the included studies)

Two reviewers (S.K. and R.S.) independently assessed the risk of bias in all included studies based on the Cochrane guidelines [24]. Reviewers were instructed to provide justifications for their assessments, to account for discrepancies, and to generate consensus ratings. Evaluated criteria included selection bias (random sequence generation and allocation concealment), performance bias (blinding of participants and personnel), detection bias (outcome assessment blinding), attrition bias (incomplete outcome data), reporting bias (selective reporting), and other sources of bias (baseline imbalance and differential attrition). Each criterion was rated as low, high, or unclear [24]. Any disagreements between the independent reviewers were resolved through group discussions.

Data extraction

Two independent reviewers (S.K. and R.S.) extracted the data based on the Cochrane guidelines [24]. Extracted data included the mean and standard deviation (SD) of the pre- and posttest values in each group, the mean and SD values of changes in scores in each group, and the t score or p value within groups. Comprehensive Meta-Analysis Software (version 3) was used to estimate effect sizes (standardized differences in means [SDMs]) with 95% confidence intervals (CIs), and Egger’s regression test (p>.050) assessed publication bias with funnel plots as a reference. Heterogeneity was assessed using forest plots and I2 tests (>50%) to quantify inconsistencies in the included studies [25]. Effect sizes were calculated using a random-effects model as there were differences in disease type or composition and duration of the intervention [26].

According to the research purposes, a subgroup analysis was conducted to compare the program effects according to the program duration, program provider, the type of comparisons, and program settings.

Results and discussion

Participant characteristics and study settings

Our database searches identified 13,437 publications (5,095 studies on patients with lifestyle-related chronic disease) (Fig 1). Duplicate citations (k = 446) were removed using bibliographic software, leaving 12,991 citations for screening of the title and Abstract. After the initial screening of the inclusion and exclusion criteria, 64 full-text articles were reviewed. As listed in Table 1, 25 RCTs met the inclusion criteria and were included in the meta-analysis. All studies were published from 2003 to 2020. Nine studies were conducted in the USA, and the rest were conducted in China, Japan, Thailand, Australia, Canada, France, India, the Netherlands, Norway, and Canada. Participants were recruited from the community or a hospital. Among the cardiovascular risk factors, 14 studies applied SMPs to adults with diabetes, hypertension, hyperlipidemia, metabolic syndrome, or obesity.

Fig 1. PRISMA flow diagram.

Fig 1

Table 1. Qualitative description of included studies.

First author and Year Country and setting Health condition N (E/C) Age, years (E/C) Measurement time points Intervention duration/ type/content Intervention/ provider Comparisons Outcome variables
Dongbo 2003 China Community HTN, heart disease, DM 430/349 64.2/63.8 Baseline, 6M 7W/group 2–2.5h/W×7 CDSMP/peer No treatment PA (CDSMP) HR (CDSMP)
Steed 2005 UK Hospital DM 65/59 59.2/60.3 Baseline, 3M, 6M 3M/group 2.5h×5+2.5h×1 (booster) SMP/nurse, dietician Usual care Diet (SCDA) Smoking cessation (SCDA)
Hibbard 2007 USA Community DM, HTN, heart disease 244/235 59.6/60.0 Baseline, 6W, 6M Over 6W/group 2.5h×6 CDSMP/peer No treatment HR (PAM, health behaviors) Stress management (health related behaviors)
Lorig 2008 USA unity DM 219/198 52.9/52.8 Baseline, 6M, 18M 6W/group 2.5h/W×6 SMP/peer Usual care PA (physical activities scale) HR (glucose monitoring, health care utilization)
Lorig 2009 USA Community DM 186/159 67.7/65.4 Baseline, 6M, 12M 6W/group 2.5h/W×6 SMP/peer Usual care PA (health activity scale) Diet (healthy eating) HR (PAM, health care utilization)
Moriyama 2009 Japan Hospital DM 42/23 66.4/65.2 Baseline, 3M, 6M, 9M, 12M 12M/individual 30m×12 interview+1/2W call+interview SMP/nurse Usual care PA (goal attainment for exercise) Diet (goal attainment for diet)
McGowan 2011 Canada Hospital DM 82/152 55/59 Baseline, 6M 6W/group DM education 2.5h/W×6 CDSMP/peer Regular DM education by a dietitian PA (self-management behavior) HR (medical care utilization)
Rujiwatthanakorn2011 Thailand Hospital HTN 50/46 61.2/60.9 Baseline, 14W 10W/group 2h×3+6 (letters) SMP/primary investigator Usual care HR (SCABPCQ) Stress management (SCABPCQ)
Glasgow 2012 USA Hospital DM 169 (E1)/162 (E2)/132 (C1) 58.7/58.7/58.7 Baseline, 4M, 12M 2M/(individual+group) 2h group+2 phone calls Internet SMP /nutritionist Usual care PA (CHAMPS) Diet (NCI percentage energy) HR (Hill-Bone Compliance scale)
Liu 2012 China Community DM 119/89 62.0/62.5 Baseline, 12M 12M/(individual+group) 1.5h/M×12+1h/M×12 visits CDSMP/doctor, nurse practitioner Usual care PA (self-management behavior) Diet (self-management behavior) HR (self-management behavior)
Rygg 2012 Norway Hospital DM 73/73 66 Baseline, 6M, 12M 3W/group 15h over 3 sessions SMP/nurse Usual care HR (PAM)
Suwankruhasn 2013 Thailand Hospital Metabolic syndrome 44/42 59.6/62.7 Baseline, 3M, 6M 3M/group 2h/W×4+1/M×2 SMP/nurse Usual care PA (physical activity log) Diet (7-day food diary)
Trouilloud 2013 France Hospital DM 120 56.7 Baseline, 3M 3 days/group 2–3h×8 SMP/nurse No treatment Diet (DM self-care activity)
Forjuoh 2014 USA Community DM 101/95 57.6 Baseline, 6M, 12M 6W/group 2.5h/W×6 CDSMP/peer Usual care Diet (DSCA) HR (DSCA)
Lynch 2014 USA Community DM, HTN 31/30 54.8/53.4 Baseline, 6M 2W/group 3h×2+2h follow-up SMP/community health worker, expert Group education for nutrition and exercise Diet (DSCA) HR (MMTAS)
Miller 2014 USA Community DM 25/27 54.0/53.9 Baseline, 3M, 6M 3M/group 2.5h×10 SMP/dietitian Group-based mindful eating intervention Diet (BFFQ)
Vinkers 2014 The Netherlands Community Obesity 45/60 55.8/55.8 Baseline, 2M, 7M, 12M 6M/(individual+group) 1h×1, 2h×4+2h×2 (booster) SMP/dieticians Group session with written assignments PA (PASE) Diet (KFHQ)
Whittle 2014 USA Community HTN 219/185 68.8/67.4 Baseline, 12M 12M/group 10m×12 SMP/peer Health education PA (health survey)
Baig 2015 USA Community DM 50/50 51.7/55.7 Baseline, 3M, 6M 8W/group 90m/W×8 SMP/peer Health education PA (SDSCA) Diet (SDSCA) HR (SDSCA)
Meng 2016 Germany Hospital CHF 248/227 Baseline, 3M, 6M, 12M 3W/group 60–75m×5 SMP/physician, nurse, psychologist, physiotherapist Education PA (Godin Leisure-Time Exercise Questionnaire) Diet (symptom monitoring: 4 items) HR (MARS-D, symptom monitoring: 3 items)
Sadeghian 2016 India Hospital DM 152/154 45.4 Baseline 6M 2W/group 2h/W×2 SMP/expert DM education PA (questionnaire) Smoking cessation (questionnaire)
Nishimura 2017 Japan Hospital DM 30/32 66.7/65.8 Baseline, 6M 6M/group 1/2M×3 SMP/health care staff Usual care HR (SDSCA)
Huang 2018 China Hospital HTN 46/44 54.6/54.5 Baseline, 1M, 3M, 6M 5W/(individual+group) 45m/W×3+motivational interviewing SMP/nurse Standard care plus routine health education Diet (balance formulas) HR (medication-taking behavior scale)
Agarwal 2019 Canada Community DM, HTN 28/22 64.2/63.9 Baseline, 4M 4M/individual 1/W×16 home visits+phone calls+HL app+discussion SMP/peer Usual care PA (RAPA)
Engelen 2020 The Netherlands Hospital CVD 103/105 63.3/63.7 Baseline, 6M, 12M 12M/individual 6 modules×4 SMP/health professionals Usual care PA (IPAQ) Diet (DHD Index) HR (PAM) Smoking (FTND)

Notes: N, population size; E, experimental group; C, comparison group; m, minutes; M, months; W, weeks; h, hours; PA, physical activity; HR, health responsibility; CDSMP, Chronic Disease Self-Management Program; SMP, self-management program; PAM, Patient Activation Measure; HTN, hypertension; PASE, Physical Activity Scale for the Elderly; KFHQ, Kristal Food Habits Questionnaire; BFFQ, Block 2005 Food Frequency Questionnaire; SCABPCQ, Self-Care Ability for Blood Pressure Control Questionnaire; SDSCA, Diabetes Self-Care Activities; SCDA, Self-Care Diabetes Activities; CHAMPS, Community Healthy Activities Model Program for Seniors; NCI, US National Cancer Institute; DSCA, Diabetes Self-Care Activities; MMTAS, Morisky Medication Adherence Scale; MARS-D, Medication Adherence Report Scale; HL app, healthy lifestyle application; RAPA, Rapid Assessment of Physical Activity; IPAQ, International Physical Activity Questionnaire; DHD Index, Dutch Healthy Diet Index; FTND, Fagerstrom Test for Nicotine Dependence; DM, diabetes mellitus; CHF, congestive heart failure; CVD, cardiovascular disease.

Assessment of risk of bias in RCTs

The risk of bias was low in all 25 RCTs (Fig 2). A specific random sequence or an allocation concealment process were reported for 18 (72%) and 16 (64%) studies, respectively. Participant and researcher blinding was impossible in most studies due to the characteristics of the RCTs, and blinding of the outcome assessments were reported for six studies (24%). All studies had a low dropout rate (<20%). The timing of outcome assessments was reported for all studies. All studies also had a low risk of selection bias. Our meta-analysis therefore included all 25 studies.

Fig 2. Summary of the risk of bias.

Fig 2

Intervention and control group characteristics

Self-management interventions differed in their contents, durations, providers, and intensities (Table 1). The SMP sessions lasted from 10 to 180 minutes, and there were from 2 to 12 sessions. The overall SMP duration ranged from 3 days to 12 months. Each SMP was conducted on an individual basis (k = 18), group basis (k = 3), or a combination of both (k = 4). SMPs were delivered by either an expert (k = 16; health professionals, dieticians, or psychologists) or a peer (k = 9). The various components of SMP were considered, including education, interview, home visits, letters, phone calls, and discussions using health lifestyle apps.

The comparison groups mostly received the usual care or no treatment (k = 16), while nine studies considered group education as written assignments [27], mindful eating interventions [28], diabetes education [21, 29], health education [30, 31], or nutrition and exercise education [32].

Primary analyses

Fig 3 shows the random-effects model, which calculated the effects of SMP on physical activity, dietary habits, health responsibility, stress management, and smoking. Subgroup analyses were conducted based on program duration (short term [<12 weeks] vs. long-term [≥12 weeks]), program provider (expert vs. peer), the type of comparisons (active control [education or physical activity] vs. passive control [usual care or no treatment]), and program settings (hospital vs. community).

Fig 3. Forest plots of the effects of self-management programs (SMPs) on health behaviors.

Fig 3

Notes: SDM, standardized difference in means; Cl, confidence interval; LL, lower limit; UL, upper limit.

Physical activities

Assessment of physical activity was an outcome of the SMP in 20 studies, as measured using physical activities scales [33, 34], exercise goal attainment [35], physical activity [36], the Physical Activity Scale for the Elderly [27], the Community Healthy Activities Model Program for Seniors [37], and a physical activity log book [38].

From the random-effects model, the pooled effect size of 20 studies for physical activities was small but significant (SMD = 0.25, 95% CI = 0.16~0.34, I2 = 49.5%) but potentially had publication bias (p = .039). The subgroup analyses were conducted for program duration, program provider, type of comparisons and program settings. The effect of short-term SMP (k = 12) was SMD = 0.23 (95% CI = 0.13~0.34, I2 = 29.9%) with potential publication bias (p = .008), while the effect of long-term SMP (k = 8) was SMD = 0.29 (95% CI = 0.11~0.46, I2 = 66.9%) with no publication bias (p = .587). No significant difference was found on the effect size of different intervention durations (Q = 0.25, p = .614) (Fig 3A).

Subgroup analyses on program providers revealed that the effect size of SMP on expert providers (k = 13) was SMD = 0.28 (95% CI = 0.16~0.41, I2 = 63.0%) with no publication bias (p = .094), while that of peer providers (k = 7) was SMD = 0.20 (95% CI = 0.05~0.35, I2 = 0.0%) with no publication bias (p = .354). The difference between the effect sizes of the program providers was not significant (Q = 0.75, p = .388) (Fig 3B).

Six of the 20 RCTs in which physical activity was assessed used active control for comparisons, while the other 14 compared SMP with usual care or no treatment controls. The effect size of the SMP on physical activity with active control was SMD = 0.19 (95% CI = 0.02~0.37, I2 = 0.0%) with potential publication bias (p = .079). When SMP was compared with usual care or no treatment control, the effect size was larger (SMD = 0.27, 95% CI = 0.16~0.38, I2 = 60.9%) with no publication bias (p = .105). The difference between the effect sizes of the control groups was not significant (Q = 0.55, p = .457) (Fig 3C).

Subgroup analysis on program settings revealed that the community based SMP (k = 8) had a smaller effect size (SMD = 0.21, 95% CI = 0.07~0.35, I2 = 0.0%) than the hospital based SMP (k = 7, SMD = 0.28, 95% CI = 0.15~0.41, I2 = 64.4%). No publication bias was suspected, and the difference between the program settings was not significant (Q = 0.45, p = .504) (Fig 3D).

Dietary habits

Fifteen studies assessed dietary habits by healthy eating [33], diet goal attainment [35], dietary activities [36], Kristal’s Food Habits Questionnaire [27], Block 2005 Food Frequency Questionnaire [28], questions on fatty food avoidance and vegetable intake [39], USA National Cancer Institute percent energy [37], and a 7-day food diary [38].

The total effect of SMPs on dietary habits was small but significant (SMD = 0.28, 95% CI = 0.15~0.41, I2 = 65.6%) in 19 studies with no publication bias (p = .117). Subgroup analyses by intervention duration showed that the effect of short-term SMP (k = 11) was SMD = 0.30 (95% CI = 0.14~0.47, I2 = 70.4%) with no publication bias (p = .121), while the effect of long-term SMP (k = 8) was SMD = 0.24 (95% CI = 0.03~0.46, I2 = 61.8%) with no publication bias (p = .218). The subgroup comparison revealed no significant differences (Q = 0.21, p = .647) (Fig 3E).

Most SMPs were provided by an expert (k = 15) with an effect size on dietary habits of SMD = 0.29 (95% CI = 0.14~0.44, I2 = 70.7%) with no publication bias (p = .152). Only four studies had a peer as the provider, and the effect size was not significant (95% CI = –0.02~0.52, I2 = 33.2%) with no publication bias (p = .594) (Fig 3F).

SMPs for dietary habits were mostly compared with inactive control (k = 13) with an effect size of SMD = 0.31 (95% CI = 0.16~0.47, I2 = 72.2%) and no publication bias (p = .141). The effect size of the SMP with active control (k = 6) was not significant (95% CI = –0.05~0.44, I2 = 31.1%) with no publication bias (p = .347) (Fig 3G).

Subgroup analysis on program settings revealed that the community based SMP (k = 9) had a smaller effect size (SMD = 0.21, 95% CI = 0.02~0.40, I2 = 0.0%) than the hospital based SMP (k = 10, SMD = 0.34, 95% CI = 0.16~0.52, I2 = 79.4%). No publication bias was suspected, and the difference between the program settings was not significant (Q = 0.93, p = .334) (Fig 3H).

Health responsibilities

Health responsibilities were an outcome in 16 studies, which included glucose monitoring [33, 34], health care utilization [29, 33, 34, 39, 40], communication with physician [33, 34], food label reading [33], feet inspection [39], medication adherence [39], Patient Activation Measure [10, 33, 39], medication adherence [36], Hill-Bone Compliance to High Blood Pressure Therapy Scale [37], and Morisky Medication Adherence Scale [32].

The total effect size of SMPs on health responsibility (k = 18) was small but significant (SMD = 0.18, 95% CI = 0.10~0.26, I2 = 82.8%) with potential publication bias (p = .032). The subgroup analysis indicated that the effect size of the short-term SMP on health responsibility (k = 14) was SMD = 0.19 (95% CI = 0.10~0.29, I2 = 86.4%) but there was potential for publication bias (p = .040). Only four studies compared the long-term SMP, which had an insignificant effect size (95% CI = –0.05~0.32, I2 = 0.8%) and no publication bias (p = .481) (Fig 3I).

SMPs delivered by expert providers (k = 10) had a small but significant effect size of SMD = 0.25 (95% CI = 0.13~0.37, I2 = 79.5%) with no publication bias (p = .082). The SMP effect size with peer providers (k = 8) was small but significant (SMD = 0.12, 95% CI = 0.01~0.23, I2 = 85.5%) with no publication bias (p = .429). There were no significant differences in effect sizes between the program provider groups (Q = 2.49, p = .115) (Fig 3J).

The SMPs utilizing active control (k = 6) tended to have larger effect sizes (SMD = 0.22, 95% CI = 0.07~0.37, I2 = 89.1%) than those with passive control (k = 12) (SMD = 0.16, 95% CI = 0.06~0.27, I2 = 76.8%), and had no publication bias (p = .262, p = .107, respectively). No significant difference on effect size was found between these groups (Q = 0.42, p = .519) (Fig 3K).

The subgroup analysis on program settings indicated that the community based SMP (k = 9) was not significant (95% CI = 0.00~0.21, I2 = 80.2%), while the hospital based SMP (k = 7) has a significant small effect size (SMD = 0.27, 95% CI = 0.15~0.38, I2 = 81.7%). No publication bias was suspected (p = .124) (Fig 3L).

Stress management

Only two studies assessed the effects of SMPs on stress management, which was measured using 18 health-related behaviors [10] and SCABPCQ [41]. The effect size for SMPs on stress management was not significant (SDM = 0.12, 95% CI = –0.04~0.29) and had low heterogeneity (I2 = 0.0%) (Fig 3M).

Smoking behavior

Only three studies assessed the effects of SMPs on smoking behavior, which was measured by a smoking cessation questionnaire [21, 22] or the Fagerstrom Test for Nicotine Dependence [23]. The random-effects model indicated that the SMP effect size on smoking behavior was not significant (SDM = –0.12, 95% CI = –0.78~0.54) and had moderate heterogeneity (I2 = 48.5%) and no publication bias (p = .999) (Fig 3N).

Discussion

This systematic review and meta-analysis evaluated 25 RCTs that used SMPs and were performed worldwide, and found that SMPs were effective on behavioral modification, specifically physical activity, dietary habits, and health responsibility. There were no significant effects on stress management and smoking behavior due to the relatively small number of studies that assessed these behavioral outcomes. Several parameters varied in the SMPs promoting behavioral modification for individuals with lifestyle-related chronic disease, including control conditions, intervention durations, program providers, and program settings. We used a random-effects model to consider the assumption that different studies estimated different treatment effects from SMP [26].

An SMP has been supported as an effective intervention to improve medication adherence, which we defined as health responsibility [42]. Our findings are similar to those in previous meta-analyses, which found SMPs to have significant effects on health responsibilities, including improved medication adherence and decreased use of hospitals for asthma and stroke patients [43]. However, no significance differences in stress management and smoking behaviors were found between the experimental and control groups, which is likely due to the relatively small number of studies that we analyzed.

The SMP intervention duration ranged from 3 days to 12 months with a frequency range of 3 to 12 sessions. Most of the included studies (k = 14) applied a short-term SMP with a cutoff of less than 12 weeks, and had a small but significant effect size for improving physical activity, dietary habits, and health responsibility. Our meta-analysis indicated that the effect size of long-term SMPs was similar to of short-term SMPs except for health responsibility, suggesting that SMP lasting for up to 12 weeks can effectively modify the behaviors of individuals with cardiovascular risk factors. Previous meta-analyses of chronic disease SMPs with durations of 4~6 months found small but significant effect sizes on aerobic exercise (SMD = 0.12) and health responsibility (communication with physician: SMD = 0.26) [44]. In the current analysis, the long-term effect of SMPs on health responsibility was not significant, probably due to the small number of the studies (k = 4) included in the meta-analysis.

In our subgroup analysis on the type of comparisons, SMPs was effective to promote physical activity and health responsibilities, regardless of using active or inactive controls. However, the SMPs applied to modify dietary habits was only effective when compared with inactive controls. Only 6 studies applied active controls to compare the effect of SMPs on dietary habits, which could be the reason for not significant effects.

The effects of expert- and peer-delivered programs on physical activity, dietary habits, and health responsibility were also compared. Previous research indicated that health education provided by experts from multidisciplinary teams had large effects on behavioral modification [45]. However, the effects of the SMPs when they were delivered by experts was not significantly different when compared with peer-delivered programs for physical activity and health responsibility. The SMPs was effective on dietary habits only when delivered by experts (e.g., dietitians or health professionals).

The effects of the SMP may vary according to the program settings. In our meta-analysis, both hospital-based and community-based SMPs were found significant on improving physical activities and dietary habits, but only the effect of hospital-based SMPs was significant on health responsibility. Health responsibility as behavioral outcome refers to health care utilization, glucose monitoring, or medication adherence. Previous meta-analysis on lay-led self-management program [46] also found the mixed results regarding appropriate health care utilization, in that the SMP approach may encourage the participants to seek medical advice or could reduce the unplanned hospital visits.

There were several limitations in this systematic review and meta-analysis. First, we examined the effects immediately after interventions and did not include follow-up data. There are currently insufficient follow-up data for examining the long-term effects of SMPs on behavior modification. Further studies should consider follow-up data and analyze the long-term retention of SMP effects on behavioral modification, which may improve the management of lifestyle-related chronic disease. Second, only studies in English and Korean were included, which may reduce the generalizability of our findings. Third, relatively few randomized studies were available that analyzed stress management and smoking-related behaviors, and so further studies are necessary to evaluate the effect of SMP on these specific health behaviors based on delivery mode (group vs. individual, online vs. offline, and program intensity).

Conclusions

The findings of this study indicate that SMPs can effectively improve physical activity, dietary habits, and health responsibility in individuals with lifestyle-related chronic disease, with a small but significant effect size. A short-term SMPs (less than 12 weeks) was indicated as being effective in modifying physical activity, dietary habits, and health responsibility, while the program effects on dietary habits were significant only with expert-delivered education and when compared with inactive controls. Further studies are warranted with larger trials and more rigorous methodologies that explore the effects of SMPs on stress management and smoking cessation and examine long-term outcomes of the SMPs.

Supporting information

S1 Checklist

(DOCX)

S1 File

(PDF)

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

This research was supported by basic science research program through the National Research Foundation of Korea (NRF- 2017R1A2B4006775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Heart disease facts [Internet]. Centers for Disease Control and Prevention. 2020 [cited January 30, 2021]. https://www.cdc.gov/heartdisease/facts.htm.
  • 2.Cardiovascular disease [Internet]. World Health Organization. 2017 [cited January 30, 2021]. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
  • 3.Remington PL, Brownson RC, Wegner MV. Chronic disease epidemiology and control. Washington: American Public Health Association; 2010. xii + 659 p. [Google Scholar]
  • 4.Åkesson A, Larsson SC, Discacciati A, Wolk A. Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: A population-based prospective cohort study. J Am Coll Cardiol. 2014;64(13):1299–306. doi: 10.1016/j.jacc.2014.06.1190 [DOI] [PubMed] [Google Scholar]
  • 5.Lorig KR, Hurwicz ML, Sobel D, Hobbs M, Ritter PL. A national dissemination of an evidence-based self-management program: a process evaluation study. Patient Educ Couns. 2005;59(1):69–79. Epub 2005/10/04. doi: 10.1016/j.pec.2004.10.002 [DOI] [PubMed] [Google Scholar]
  • 6.Manns BJ, Tonelli M, Zhang J, Campbell DJT, Sargious P, Ayyalasomayajula B, et al. Enrolment in primary care networks: impact on outcomes and processes of care for patients with diabetes. CMAJ. 2012;184(2):E144. doi: 10.1503/cmaj.110755 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.McAlister FA, Majumdar SR, Eurich DT, Johnson JA. The effect of specialist care within the first year on subsequent outcomes in 24 232 adults with new-onset diabetes mellitus: population-based cohort study. Qual Saf Health Care. 2007;16(1):6. doi: 10.1136/qshc.2006.018648 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Shah BR, Hux JE, Austin PC. Diabetes Is Not Treated as a Coronary Artery Disease Risk Equivalent. Diabetes Care. 2007;30(2):381. doi: 10.2337/dc06-1654 [DOI] [PubMed] [Google Scholar]
  • 9.Toth EL, Majumdar SR, Guirguis LM, Lewanczuk RZ, Lee TK, Johnson JA. Compliance with clinical practice guidelines for type 2 diabetes in rural patients: treatment gaps and opportunities for improvement. Pharmacotherapy. 2003;23(5):659–65. Epub 2003/05/14. doi: 10.1592/phco.23.5.659.32203 [DOI] [PubMed] [Google Scholar]
  • 10.Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors? Health Serv Res. 2007;42(4):1443–63. Epub 2007/07/06. doi: 10.1111/j.1475-6773.2006.00669.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Rejeski WJ, Ip EH, Bertoni AG, Zhang Q, Bray GA, Evans G, et al. Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med. 2012;366(13):1209–17. doi: 10.1056/NEJMoa1110294 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lorig KR. Chronic disease self-management program: insights from the eye of the storm. Front Public Health. 2014;2:253. Epub 2014/01/01. doi: 10.3389/fpubh.2014.00253 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99(6):926–43. Epub 2015/12/15. doi: 10.1016/j.pec.2015.11.003 [DOI] [PubMed] [Google Scholar]
  • 14.Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12. Epub 2009/07/28. doi: 10.1016/j.jclinepi.2009.06.005 [DOI] [PubMed] [Google Scholar]
  • 15.Song R, Oh H, Ahn S, Moorhead S. Validation of the cardiac health behavior scale for Korean adults with cardiovascular risks or diseases. Appl Nurs Res. 2018;39:252–8. Epub 2018/02/10. doi: 10.1016/j.apnr.2017.11.011 [DOI] [PubMed] [Google Scholar]
  • 16.Beck J, Greenwood DA, Blanton L, Bollinger ST, Butcher MK, Condon JE, et al. 2017 National Standards for Diabetes Self-Management Education and Support. Diabetes Educ. 2018;44(1):35–50. Epub 2018/01/19. doi: 10.1177/0145721718754797 [DOI] [PubMed] [Google Scholar]
  • 17.Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. Epub 2011/04/26. doi: 10.1186/1748-5908-6-42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rosenstock IM. Why people use health services. The Milbank Quarterly. 2005;83(4). [Google Scholar]
  • 19.Suchman EA. Preventive health behavior: a model for research on community health campaigns. J Health Soc Behav. 1967;8(3):197–209. Epub 1967/09/01. [PubMed] [Google Scholar]
  • 20.Steptoe A, Kivimäki M. Stress and cardiovascular disease: an update on current knowledge. Annu Rev Public Health. 2013;34:337–54. doi: 10.1146/annurev-publhealth-031912-114452 [DOI] [PubMed] [Google Scholar]
  • 21.Sadeghian HA, Madhu SV, Agrawal K, Kannan AT, Agrawal K. Effects of a self-management educational program on metabolic control in type 2 diabetes. Turk J Med Sci. 2016;46(3):719–26. Epub 2016/08/12. doi: 10.3906/sag-1501-115 [DOI] [PubMed] [Google Scholar]
  • 22.Steed L, Lankester J, Barnard M, Earle K, Hurel S, Newman S. Evaluation of the UCL diabetes self-management programme (UCL-DSMP): a randomized controlled trial. J Health Psychol. 2005;10(2):261–76. Epub 2005/02/23. doi: 10.1177/1359105305049775 [DOI] [PubMed] [Google Scholar]
  • 23.Engelen MM, van Dulmen S, Puijk-Hekman S, Vermeulen H, Nijhuis-van der Sanden MW, Bredie SJ, et al. Evaluation of a Web-Based Self-Management Program for Patients With Cardiovascular Disease: Explorative Randomized Controlled Trial. J Med Internet Res. 2020;22(7):e17422. Epub 2020/07/25. doi: 10.2196/17422 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. Epub 2011/10/20. doi: 10.1136/bmj.d5928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. Epub 2003/09/06. doi: 10.1136/bmj.327.7414.557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111. Epub 2010/04/01. doi: 10.1002/jrsm.12 [DOI] [PubMed] [Google Scholar]
  • 27.Vinkers CD, Adriaanse MA, Kroese FM, de Ridder DT. Efficacy of a self-management intervention for weight control in overweight and obese adults: a randomized controlled trial. J Behav Med. 2014;37(4):781–92. Epub 2013/08/21. doi: 10.1007/s10865-013-9530-9 [DOI] [PubMed] [Google Scholar]
  • 28.Miller CK, Kristeller JL, Headings A, Nagaraja H. Comparison of a mindful eating intervention to a diabetes self-management intervention among adults with type 2 diabetes: a randomized controlled trial. Health Educ Behav. 2014;41(2):145–54. doi: 10.1177/1090198113493092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.McGowan P. The efficacy of diabetes patient education and self-management education in type 2 diabetes. Can J Diabetes. 2011;35(1):46–53. doi: 10.1016/S1499-2671(11)51008-1 [DOI] [Google Scholar]
  • 30.Baig AA, Benitez A, Locklin CA, Gao Y, Lee SM, Quinn MT, et al. Picture good health: a church-based self-management intervention among Latino adults with diabetes. J Gen Intern Med. 2015;30(10):1481–90. doi: 10.1007/s11606-015-3339-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Whittle J, Schapira MM, Fletcher KE, Hayes A, Morzinski J, Laud P, et al. A randomized trial of peer-delivered self-management support for hypertension. Am J Hypertens. 2014;27(11):1416–23. Epub 2014/04/24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lynch EB, Liebman R, Ventrelle J, Avery EF, Richardson D. A self-management intervention for African Americans with comorbid diabetes and hypertension: a pilot randomized controlled trial. Prevent Chronic Dis. 2014;11:E90–E. doi: 10.5888/pcd11.130349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lorig K, Ritter PL, Villa FJ, Armas J. Community-based peer-led diabetes self-management: a randomized trial. Diabetes Educ. 2009;35(4):641–51. Epub 2009/05/02. doi: 10.1177/0145721709335006 [DOI] [PubMed] [Google Scholar]
  • 34.Lorig K, Ritter PL, Villa F, Piette JD. Spanish diabetes self-management with and without automated telephone reinforcement: two randomized trials. Diabetes Care. 2008;31(3):408–14. doi: 10.2337/dc07-1313 [DOI] [PubMed] [Google Scholar]
  • 35.Moriyama M, Nakano M, Kuroe Y, Nin K, Niitani M, Nakaya T. Efficacy of a self-management education program for people with type 2 diabetes: results of a 12 month trial. Jpn J Nurs Sci. 2009;6(1):51–63. Epub 2009/07/02. doi: 10.1111/j.1742-7924.2009.00120.x [DOI] [PubMed] [Google Scholar]
  • 36.Trouilloud D, Regnier J. Therapeutic education among adults with type 2 diabetes: effects of a three-day intervention on perceived competence, self-management behaviours and glycaemic control. Glob Health Promot. 2013;20(2 Suppl):94–8. Epub 2013/05/25. doi: 10.1177/1757975913483331 [DOI] [PubMed] [Google Scholar]
  • 37.Glasgow RE, Kurz D, King D, Dickman JM, Faber AJ, Halterman E, et al. Twelve-month outcomes of an Internet-based diabetes self-management support program. Patient Educ Couns. 2012;87(1):81–92. Epub 2011/09/20. doi: 10.1016/j.pec.2011.07.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Suwankruhasn N, Pothiban L, Panuthai S, Boonchuang P. Effects of a self-management support program for Thai people diagnosed with metabolic syndrome. Pac Rim Int J Nurs Res Thail. 2013;17(4):371–83. [Google Scholar]
  • 39.Rygg LO, Rise MB, Gronning K, Steinsbekk A. Efficacy of ongoing group based diabetes self-management education for patients with type 2 diabetes mellitus. A randomised controlled trial. Patient Educ Couns. 2012;86(1):98–105. Epub 2011/05/20. doi: 10.1016/j.pec.2011.04.008 [DOI] [PubMed] [Google Scholar]
  • 40.Fu D, Fu H, McGowan P, Shen YE, Zhu L, Yang H, et al. Implementation and quantitative evaluation of chronic disease self-management programme in Shanghai, China: randomized controlled trial. Bull World Health Organ. 2003;81(3):174–82. Epub 2003/05/24. [PMC free article] [PubMed] [Google Scholar]
  • 41.Rujiwatthanakorn D, Panpakdee O, Malathum P, Tanomsup S. Effectiveness of a self-management program for Thais with essential hypertension. Pac Rim Int J Nurs Res Thail. 2011;15(2):97–110. [Google Scholar]
  • 42.Li R, Liang N, Bu F, Hesketh T. The Effectiveness of Self-Management of Hypertension in Adults Using Mobile Health: Systematic Review and Meta-Analysis. JMIR Mhealth Uhealth. 2020;8(3):e17776. Epub 2020/03/29. doi: 10.2196/17776 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.McLean G, Murray E, Band R, Moffat KR, Hanlon P, Bruton A, et al. Interactive digital interventions to promote self-management in adults with asthma: systematic review and meta-analysis. BMC Pulm Med. 2016;16(1):83. Epub 2016/05/25. doi: 10.1186/s12890-016-0248-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Brady TJ, Murphy L, O’Colmain BJ, Beauchesne D, Daniels B, Greenberg M, et al. A meta-analysis of health status, health behaviors, and health care utilization outcomes of the Chronic Disease Self-Management Program. Prev Chronic Dis. 2013;10:120112. Epub 2013/01/19. doi: 10.5888/pcd10.120112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.van Eikenhorst L, Taxis K, van Dijk L, de Gier H. Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes. A Systematic Literature Review and Meta-Analysis. 2017. doi: 10.3389/fphar.2017.00891 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Lederle M, Bitzer EM. A close look at lay-led self-management programs for chronic diseases and health care utilisation: A systematic review and meta-analysis. Ger Med Sci. 2019;17:Doc03. Epub 2019/06/01. doi: 10.3205/000269 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Checklist

(DOCX)

S1 File

(PDF)

Data Availability Statement

All relevant data are within the manuscript and its Supporting information files.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES